FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

1476511000001107: Distalgesic 32.5mg/325mg tablets (Meda Pharmaceuticals Limited) 100 tablet (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
24708101000001112 Distalgesic 32.5mg/325mg tablets (Meda Pharmaceuticals Limited) 100 tablet (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
37926501000001112 Distalgesic 32.5mg/325mg tablets (Meda Pharmaceuticals Ltd) 100 tablet 10 x 10 tablets en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Distalgesic 32.5mg/325mg tablets (Meda Pharmaceuticals Limited) 100 tablet Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category Schedule 5 (CD Inv) true Inferred relationship Existential restriction modifier
Distalgesic 32.5mg/325mg tablets (Meda Pharmaceuticals Limited) 100 tablet Is a Co-proxamol 32.5mg/325mg tablets 100 tablet true Inferred relationship Existential restriction modifier
Distalgesic 32.5mg/325mg tablets (Meda Pharmaceuticals Limited) 100 tablet Is pack of Distalgesic 32.5mg/325mg tablets (Meda Pharmaceuticals Limited) false Inferred relationship Existential restriction modifier
Distalgesic 32.5mg/325mg tablets (Meda Pharmaceuticals Limited) 100 tablet Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available true Inferred relationship Existential restriction modifier
Distalgesic 32.5mg/325mg tablets (Meda Pharmaceuticals Limited) 100 tablet Has active ingredient Dextropropoxyphene hydrochloride false Inferred relationship Existential restriction modifier
Distalgesic 32.5mg/325mg tablets (Meda Pharmaceuticals Limited) 100 tablet Has active ingredient Dextropropoxyphene false Inferred relationship Existential restriction modifier
Distalgesic 32.5mg/325mg tablets (Meda Pharmaceuticals Limited) 100 tablet Has active ingredient Paracetamol false Inferred relationship Existential restriction modifier
Distalgesic 32.5mg/325mg tablets (Meda Pharmaceuticals Limited) 100 tablet Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Distalgesic 32.5mg/325mg tablets (Meda Pharmaceuticals Limited) 100 tablet Discontinued indicator Never discontinued false Inferred relationship Existential restriction modifier
Distalgesic 32.5mg/325mg tablets (Meda Pharmaceuticals Limited) 100 tablet Legal category Prescription only medicine - legal category (qualifier value) true Inferred relationship Existential restriction modifier
Distalgesic 32.5mg/325mg tablets (Meda Pharmaceuticals Limited) 100 tablet VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Distalgesic 32.5mg/325mg tablets (Meda Pharmaceuticals Limited) 100 tablet VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Distalgesic 32.5mg/325mg tablets (Meda Pharmaceuticals Limited) 100 tablet Has manufactured dose form Conventional release oral tablet false Inferred relationship Existential restriction modifier
Distalgesic 32.5mg/325mg tablets (Meda Pharmaceuticals Limited) 100 tablet Has AMP Distalgesic 32.5mg/325mg tablets (Meda Pharmaceuticals Limited) true Inferred relationship Existential restriction modifier
Distalgesic 32.5mg/325mg tablets (Meda Pharmaceuticals Limited) 100 tablet Has specific active ingredient Paracetamol true Inferred relationship Existential restriction modifier
Distalgesic 32.5mg/325mg tablets (Meda Pharmaceuticals Limited) 100 tablet Has specific active ingredient Dextropropoxyphene hydrochloride true Inferred relationship Existential restriction modifier
Distalgesic 32.5mg/325mg tablets (Meda Pharmaceuticals Limited) 100 tablet Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Distalgesic 32.5mg/325mg tablets (Meda Pharmaceuticals Limited) 100 tablet Is a Actual medicinal product pack true Inferred relationship Existential restriction modifier
Distalgesic 32.5mg/325mg tablets (Meda Pharmaceuticals Limited) 100 tablet Discontinued indicator Discontinued AMPP(qualifier value) true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start